Statistics

Total Visits

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group70

Select a period of time:

Number of views in the range

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group15

Views

Views
October 20250
November 20252
December 20251
January 20264
February 20262
March 20266
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
United Kingdom3
Argentina2
Bolivia1
Mexico1
 

Top cities views

Views
Chicago1
Cuautitlán Izcalli1
Dallas1
La Paz1
Moreno1
Naperville1
Villa Mercedes1